|
| Sales 2022 |
3 439 M
–
–
|
| Net income 2022 |
522 M
–
–
|
| Net Debt 2022 |
1 369 M
–
–
|
| P/E ratio 2022 |
28,1x |
| Yield 2022 |
1,75% |
|
| Capitalization |
13 609 M
13 609 M
–
|
| EV / Sales 2022 |
4,35x |
| EV / Sales 2023 |
4,03x |
| Nbr of Employees |
14 300 |
| Free-Float |
97,8% |
|
| Chart OPEN TEXT CORPORATION |
|
Duration : Auto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax.
Period : DayWeek
|
|
|
|
Technical analysis trends OPEN TEXT CORPORATION
|
Short Term |
Mid-Term |
Long Term |
| Trends |
Neutral |
Neutral |
Neutral |
Income Statement Evolution
Please enable JavaScript in your browser’s settings to use dynamic charts.
|
Sell
Buy
|
| Mean consensus |
BUY |
| Number of Analysts |
10 |
| Last Close Price |
50,37 $ |
| Average target price |
59,50 $ |
| Spread / Average Target |
18,1% |
Please enable JavaScript in your browser’s settings to use dynamic charts.
|
Source: https://www.marketscreener.com/quote/stock/OPEN-TEXT-CORPORATION-10374/news/A-staged-approach-to-achieving-clinical-data-intelligence-36876029/
